McHugh R Kathryn, Votaw Victoria R, Trapani Emma W, McCarthy Megan D
Division of Alcohol, Drugs, and Addiction, McLean Hospital, Belmont, MA, United States.
Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
Front Psychiatry. 2023 Mar 9;14:1129447. doi: 10.3389/fpsyt.2023.1129447. eCollection 2023.
Benzodiazepines and non-benzodiazepine hypnotics (z-drugs) are commonly prescribed for their anxiolytic and hypnotic properties, though they can also be misused. In studies examining the epidemiology of prescription drug misuse, these medication classes are commonly combined, rendering inadequate knowledge of their patterns of misuse. The objective of this study was to characterize the population prevalence, conditional dependence, and sociodemographic and clinical correlates of the misuse of benzodiazepines and z-drugs.
Data from the National Survey on Drug Use and Health from 2015 to 2019 were used to estimate population-level prevalence and characteristics of benzodiazepine and z-drug misuse. Groups were derived based on past-year misuse of benzodiazepines alone, z-drugs alone, or both drug types. Unadjusted regression analyses were used to compare groups on characteristics of interest.
Exposure to benzodiazepines and/or z-drugs prescription or misuse was common; however, only 2% of the population was estimated to have misused a benzodiazepine in the past year, and less than 0.5% misused z-drugs. People who misused only z-drugs were generally older, more likely to have health insurance, more educated, and had less severe psychiatric symptoms. This group was also more likely to report misuse to cope with sleep difficulty. Although concurrent substance use was highly prevalent in all groups, people who misused z-drugs alone generally reported less concurrent substance use than the other groups.
The misuse of z-drugs is less common than benzodiazepines, and people who misuse only z-drugs appear to generally have lower clinical severity. Nonetheless, a substantial subgroup of people exposed to z-drugs report concurrent, past-year use of other substances. Further research on z-drug misuse, including consideration of whether it should be grouped with other anxiolytic/hypnotic drugs, is needed.
苯二氮䓬类药物和非苯二氮䓬类催眠药(Z类药物)因其抗焦虑和催眠特性而常被处方使用,不过它们也可能被滥用。在研究处方药滥用的流行病学时,这些药物类别通常合并在一起,导致对其滥用模式的了解不足。本研究的目的是描述苯二氮䓬类药物和Z类药物滥用的人群患病率、条件依赖性以及社会人口学和临床相关性。
使用2015年至2019年全国药物使用和健康调查的数据来估计苯二氮䓬类药物和Z类药物滥用的人群水平患病率及特征。根据过去一年仅滥用苯二氮䓬类药物、仅滥用Z类药物或两种药物类型均滥用的情况进行分组。采用未调整的回归分析来比较各小组在感兴趣特征方面的差异。
接触苯二氮䓬类药物和/或Z类药物(处方或滥用)很常见;然而,估计过去一年中仅2%的人群滥用过苯二氮䓬类药物,滥用Z类药物的比例不到0.5%。仅滥用Z类药物的人通常年龄较大,更有可能拥有医疗保险,受教育程度更高,且精神症状较轻。该组也更有可能报告为应对睡眠困难而滥用药物。尽管同时使用其他物质在所有组中都非常普遍,但仅滥用Z类药物的人通常报告的同时使用其他物质的情况比其他组少。
Z类药物的滥用比苯二氮䓬类药物少见,且仅滥用Z类药物的人似乎临床严重程度一般较低。尽管如此,有相当一部分接触Z类药物的人报告在过去一年中同时使用了其他物质。需要对Z类药物滥用进行进一步研究,包括考虑是否应将其与其他抗焦虑/催眠药物归为一类。